SYnAbs & Biokit, A Werfen Company are proud to announce their success in the development of the best anti-valproic acid monoclonal antibody of the market! This case study is a new proof of the high efficiency of SYnAbs technologies for the generation of antibodies against haptens.
Exhibitor Data Sheet